市場調查報告書

治療診斷市場預測:各疾病 (神經病變,癌症,心血管疾病),各地區

Theranostics Market - Forecast (2020 - 2025)

出版商 IndustryARC 商品編碼 422607
出版日期 內容資訊 英文 103 Pages
商品交期: 2-3個工作天內
價格
治療診斷市場預測:各疾病 (神經病變,癌症,心血管疾病),各地區 Theranostics Market - Forecast (2020 - 2025)
出版日期: 2020年03月11日內容資訊: 英文 103 Pages
簡介

本報告提供全球治療診斷市場相關調查分析,提供您市場形勢,市場動態,策略性分析,市場分析 (各市場區隔)及其他,以及市場熵,主要企業等系統性資訊。

第1章 治療診斷市場:概要

第2章 摘要整理

第3章 市場形勢

  • 市場佔有率分析
  • 比較分析
  • 產品基準
  • 終端用戶分析
  • 5大財務分析

第4章 治療診斷市場:動態

  • 推動因素
  • 阻礙因素
  • 機會
  • 課題
  • 波特的五力分析

第5章 治療診斷市場:策略性分析

  • 價值鏈分析
  • 價格分析
  • 機會分析
  • 產品/市場生命週期分析
  • 供應商和經銷商

第6章 治療診斷市場:各疾病

  • 神經病變
  • 癌症
  • 心血管疾病

第7章 治療診斷市場:各地區

  • 歐洲
  • 亞太地區
  • 北美
  • 其他

第8章 治療診斷市場:熵

  • 產業擴大
  • 技術開發
  • M&A,合資企業
  • 供給契約

第9章 企業簡介

  • Abbott Laboratories
  • AmeriPath
  • Beckman Coulter
  • Dickinson & Company
  • BIOTEC Laboratories
  • Center for Disease Control and Prevention (CDC)
  • Dade Behring
  • Dianon Systems
  • Dynacare Laboratories
  • Enterix
  • EntroGen
  • Esoterix
  • Focus Diagnostics
  • Pfizer

第10章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: HCR 0396

Theranostics can be defined as the fusion of drug therapy and diagnostics to optimize effectiveness, safety, and streamline drug development. It is the combination of medical drugs with diagnostic tests and is also known as integrated medicine, pharmacodiagnostics, companion diagnostics, and Dx/Rx partnering. Theranostics involves association of diagnostics along with drug therapy in order to streamline the development of a drug which is more effective and cheaper. According to WHO, every year nearly 1o million new cases of cancer are being registered and cancer has become one of the major concern for the healthcare industry and it has become the need of the hour to develop an effective drug with minimum side effects which requires strong co-ordination between drug developers and diagnostic industry. Theranascostics is an emerging field, which is generating a strong interest from regulatory bodies and healthcare industries market.

Theranostics Market

Geographically, North America dominates the theranostics market driven by best in class healthcare and pharmaceutical infrastructure, best in industry practices, strict regulation and high degree of adherence to the rules and guidelines. North America was followed by Europe and Asia-Pacific as second and third largests market for the theranostics market. Asia Pacific is projected to have the fastest growth, owing to rapidly developing medical infrastructure, increasing medical tourism, newer regulations implementations by governing bodies, and increasing awareness amongst population in developing nations such as China and India in this region.

This report identifies the global theranostics market size in for the year 2020-2025, and forecast of the same for year 2021. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to the theranostics market.

This report segments the theranostics market on the basis of diseases and regional market as follows:

Theranostics Market research report is classified on the basis of diseases. Some of the major diseases covered in this report are as follows: Neuro Disorders, Cancers and Cardiovascular diseases

This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region

This report identifies all the major companies operating in the theranostics market. Some of the major companies' profiles in detail are as follows:

Abbott Laboratories

AmeriPath

Beckman Coulter

Dickinson & Company

BIOTEC Laboratories

1. Theranostics Market - Overview

  • 1.1. Definitions and Scope

2. Theranostics Market - Executive summary

  • 2.1. Market Revenue, Market Size and Key Trends by Company
  • 2.2. Key Trends by type of Application
  • 2.3. Key Trends segmented by Geography

3. Theranostics Market

  • 3.1. Comparative analysis
    • 3.1.1. Product Benchmarking - Top 8 companies
    • 3.1.2. Top 5 Financials Analysis
    • 3.1.3. Market Value split by Top 8 companies
    • 3.1.4. Patent Analysis - Top 8 companies
    • 3.1.5. Pricing Analysis

4. Theranostics Market Forces

  • 4.1. Drivers
  • 4.2. Constraints
  • 4.3. Challenges
  • 4.4. Porters five force model
    • 4.4.1. Bargaining power of suppliers
    • 4.4.2. Bargaining powers of customers
    • 4.4.3. Threat of new entrants
    • 4.4.4. Rivalry among existing players
    • 4.4.5. Threat of substitutes

5. Theranostics Market -Strategic analysis

  • 5.1. Value chain analysis
  • 5.2. Opportunities analysis
  • 5.3. Product life cycle
  • 5.4. Suppliers and distributors Market Share

6. Theranostics Market - By Diseases (Market Size -$Million / $Billion)

  • 6.1. Market Size and Market Share Analysis
  • 6.2. Application Revenue and Trend Research
  • 6.3. Product Segment Analysis
    • 6.3.1. Neuro Disorders
    • 6.3.2. Cancers
    • 6.3.3. Cardiovascular Diseases

7. Theranostics - By Geography (Market Size -$Million / $Billion)

  • 7.1. Theranostics Market - North America Segment Research
  • 7.2. North America Market Research (Million / $Billion)
    • 7.2.1. Segment type Size and Market Size Analysis
    • 7.2.2. Revenue and Trends
    • 7.2.3. Application Revenue and Trends by type of Application
    • 7.2.4. Company Revenue and Product Analysis
    • 7.2.5. North America Product type and Application Market Size
      • 7.2.5.1. U.S.
      • 7.2.5.2. Canada
      • 7.2.5.3. Mexico
      • 7.2.5.4. Rest of North America
  • 7.3. Theranostics - South America Segment Research
  • 7.4. South America Market Research (Market Size -$Million / $Billion)
    • 7.4.1. Segment type Size and Market Size Analysis
    • 7.4.2. Revenue and Trends
    • 7.4.3. Application Revenue and Trends by type of Application
    • 7.4.4. Company Revenue and Product Analysis
    • 7.4.5. South America Product type and Application Market Size
      • 7.4.5.1. Brazil
      • 7.4.5.2. Venezuela
      • 7.4.5.3. Argentina
      • 7.4.5.4. Ecuador
      • 7.4.5.5. Peru
      • 7.4.5.6. Colombia
      • 7.4.5.7. Costa Rica
      • 7.4.5.8. Rest of South America
  • 7.5. Theranostics - Europe Segment Research
  • 7.6. Europe Market Research (Market Size -$Million / $Billion)
    • 7.6.1. Segment type Size and Market Size Analysis
    • 7.6.2. Revenue and Trends
    • 7.6.3. Application Revenue and Trends by type of Application
    • 7.6.4. Company Revenue and Product Analysis
    • 7.6.5. Europe Segment Product type and Application Market Size
      • 7.6.5.1. U.K
      • 7.6.5.2. Germany
      • 7.6.5.3. Italy
      • 7.6.5.4. France
      • 7.6.5.5. Netherlands
      • 7.6.5.6. Belgium
      • 7.6.5.7. Spain
      • 7.6.5.8. Denmark
      • 7.6.5.7. Rest of Europe
  • 7.7. Theranostics - APAC Segment Research
  • 7.8. APAC Market Research (Market Size -$Million / $Billion)
    • 7.8.1. Segment type Size and Market Size Analysis
    • 7.8.2. Revenue and Trends
    • 7.8.3. Application Revenue and Trends by type of Application
    • 7.8.4. Company Revenue and Product Analysis
    • 7.8.5. APAC Segment - Product type and Application Market Size
      • 7.8.5.1. China
      • 7.8.5.2. Australia
      • 7.8.5.3. Japan
      • 7.8.5.4. South Korea
      • 7.8.5.5. India
      • 7.8.5.6. Taiwan
      • 7.8.5.7. Malaysia

8. Theranostics Market - Entropy

  • 8.1. New product launches
  • 8.2. M&A's, collaborations, JVs and partnerships

9. Theranostics Market Company Analysis

  • 9.1. Market Share, Company Revenue, Products, M&A, Developments
  • 9.2. Abbott Laboratories
  • 9.3. AmeriPath
  • 9.4. Beckman Coulter
  • 9.5. Dickinson & Company
  • 9.6. BIOTEC Laboratories
  • 9.7. Center for Disease Control and Prevention (CDC)
  • 9.8. Dade Behring
  • 9.9. Dianon Systems
  • 9.8. Dynacare Laboratories
  • 9.11. Enterix
  • 9.12. EntroGen
  • 9.9. Esoterix
  • 9.10. Focus Diagnostics
  • 9.15. Pfizer
  • 9.16. Company 16
  • 9.17. Company 17
  • 9.18. Company 18 and more

"*Financials would be provided on a best efforts basis for private companies"

10. Theranostics Market -Appendix

  • 10.1. Abbreviations
  • 10.2. Sources